These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4137974)

  • 1. The encephalitogenic dose response in guinea pigs of the tryptophan region of myelin basic protein.
    Young JD; Tsuchiya D; Geier M; Geier S; Westall FC; Thompson M; Cyr R; Ward E; Yurochko F
    Immunol Commun; 1974; 3(3):219-26. PubMed ID: 4137974
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of allergic encephalomyelitis using hydrosoluble adjuvant and the tryptophan region of myelin basic protein.
    Westall FC; Thompson M; Migliore-Samour D; Jollès P
    Immunol Commun; 1975; 4(4):353-9. PubMed ID: 52609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimum conditions for inducing chronic relapsing experimental allergic encephalomyelitis in guinea pigs.
    Keith AB; McDermott JR
    J Neurol Sci; 1980 Jun; 46(3):353-64. PubMed ID: 6155448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose inhibition of the tryptophan peptide induced encephalitogenicity.
    Westall FC
    Immunol Commun; 1978; 7(1):57-67. PubMed ID: 75835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative study of encephalitogenic protein and peptides in guinea pigs.
    Lindh J
    Exp Pathol (Jena); 1977; 13(4-5):280-7. PubMed ID: 71246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism.
    Coates A; Mackay IR; Crawford M
    Cell Immunol; 1974 Jun; 12(3):370-81. PubMed ID: 4142423
    [No Abstract]   [Full Text] [Related]  

  • 7. Minimum structural requirements for encephalitogen and for adjuvant in the induction of experimental allergic encephalomyelitis.
    Nagai Y; Akiyama K; Suzuki K; Kotani S; Watanabe Y; Shimono T; Shiba T; Kusumoto S; Ikuta F; Takeda S
    Cell Immunol; 1978 Jan; 35(1):158-67. PubMed ID: 74289
    [No Abstract]   [Full Text] [Related]  

  • 8. Further definition of the encephalitogenic region for guinea pigs.
    Westall FC; Thompson M
    Immunol Commun; 1977; 6(1):23-31. PubMed ID: 67993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of water-soluble adjuvant fraction from "Mycobacterium smegmatis" with encephalitogenic basic protein to induce autoimmune experimental allergic encephalomyelitis in guinea pigs (author's transl)].
    Lebar R; Voisin GA
    Ann Immunol (Paris); 1974 Nov; 125(6):911-6. PubMed ID: 4143099
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunopathologic response in guinea pigs sensitized with peripheral nervous system myelin.
    Brostoff SW; Wisniewski HM; Greenfield S; Morell P; Eylar EH
    Brain Res; 1973 Aug; 58(2):500-5. PubMed ID: 4127876
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on auto-immune encephalomyelitis in the guinea pig. I. Influence of different immunizations on antibody specificity and biological properties, relation to the incidence of the disease.
    Lebar R; Voisin GA
    Int Arch Allergy Appl Immunol; 1974; 46(1):82-103. PubMed ID: 4131024
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated immunity in experimental allergic encephalomyelitis: cross reactivity between myelin basic protein and mycobacteria antigens.
    Vandenbark AA; Burger DR; Vetto RM
    Proc Soc Exp Biol Med; 1975 Apr; 148(4):1233-6. PubMed ID: 48264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigen-induced inhibition of experimental allergic encephalomyelitis. III. Localization of an inhibitory site distinct from the major encephalitogenic determinant of myelin basic protein.
    Swanborg RH
    J Immunol; 1975 Jan; 114(1 Pt 1):191-4. PubMed ID: 46241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvanticity of synthetic polynucleotides for induction of experimental allergic encephalomyelitis in guinea pigs.
    Paterson PY; Drobish DG
    J Immunol; 1974 Dec; 113(6):1942-6. PubMed ID: 4139200
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed hypersensitivity to myelin basic protein in the passive transfer of experimental allergic encephalomyelitis.
    Falk GA; Kies MW; Alvord EC
    J Immunol; 1968 Oct; 101(4):638-44. PubMed ID: 4971475
    [No Abstract]   [Full Text] [Related]  

  • 16. Response of rat encephalitogenic T cells to synthetic peptides of guinea pig myelin basic protein.
    Vandenbark AA; Hashim G; Offner H
    Ann N Y Acad Sci; 1988; 540():337-9. PubMed ID: 2462807
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune responses to myelin basic protein in mycobacterial-induced suppression of experimental allergic encephalomyelitis.
    Lisak RP; Zweiman B
    Cell Immunol; 1974 Nov; 14(2):242-54. PubMed ID: 4143110
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigen-induced inhibition of experimental allergic encephalomyelitis. I. Inhibition in guinea pigs injected with non-encephalitogenic modified myelin basic protein.
    Swanborg RH
    J Immunol; 1972 Sep; 109(3):540-6. PubMed ID: 4626655
    [No Abstract]   [Full Text] [Related]  

  • 19. Humoral immune response in chronic relapsing experimental allergic encephalomyelitis (r-EAE) in guinea pigs.
    Olsson T; Henriksson A; Link H; Kristensson K
    Prog Clin Biol Res; 1984; 146():179-86. PubMed ID: 6201888
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of experimental allergic encephalomyelitis (EAE) in guinea pigs with homologous myelin basic protein.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1974 Jan; 112(1):392-7. PubMed ID: 4130152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.